Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

Single-dose, randomized crossover comparisons of different-strength imatinib mesylate formulations in healthy Korean male subjects.

Kim KA, Park SJ, Kim C, Park JY.

Clin Ther. 2013 Oct;35(10):1595-602. doi: 10.1016/j.clinthera.2013.08.008. Epub 2013 Sep 21.

PMID:
24060561
2.

Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.

Parrillo-Campiglia S, Ercoli MC, Umpierrez O, Rodríguez P, Márquez S, Guarneri C, Estevez-Parrillo FT, Laurenz M, Estevez-Carrizo FE.

Clin Ther. 2009 Oct;31(10):2224-32. doi: 10.1016/j.clinthera.2009.10.009.

PMID:
19922893
3.

Bioequivalence of a single 400-mg dose of imatinib 100-mg oral tablets and a 400-mg tablet in healthy adult Korean volunteers.

Lee HW, Seong SJ, Park SM, Lee J, Gwon MR, Kim HJ, Lim SM, Lim MS, Kim W, Yang DH, Yoon YR.

Int J Clin Pharmacol Ther. 2015 Jun;53(6):480-7. doi: 10.5414/CP202267.

PMID:
25881751
4.
5.

Bioequivalence of two intravenous formulations of antithrombin III: a two-way crossover study in healthy Korean subjects.

Kim KA, Lim YY, Kim SH, Park JY.

Clin Ther. 2013 Nov;35(11):1752-61. doi: 10.1016/j.clinthera.2013.08.018. Epub 2013 Oct 1.

PMID:
24094463
6.

Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.

Kim JE, Ki MH, Yoon IS, Cho HJ, Kim RS, Tae Kim G, Kim DD.

Clin Ther. 2014 Feb 1;36(2):273-9. doi: 10.1016/j.clinthera.2014.01.004.

PMID:
24529292
7.

Bioequivalence study of two imatinib formulations after single-dose administration in healthy Korean male volunteers.

Jung JA, Kim N, Yang JS, Kim TE, Kim JR, Song GS, Kim H, Ko JW, Huh W.

Drug Res (Stuttg). 2014 Dec;64(12):651-5. doi: 10.1055/s-0034-1367059. Epub 2014 Feb 18.

PMID:
24549963
8.

Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.

Lee S, Chung YJ, Kim BH, Shim JH, Yoon SH, Shin SG, Jang IJ, Yu KS.

Clin Ther. 2009 Dec;31(12):3000-8. doi: 10.1016/j.clinthera.2009.12.004.

PMID:
20110037
9.

Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.

Jiang T, Rong Z, Xu Y, Chen B, Xie Y, Chen C, Lu Y, Shen Y, Li H, Sun J, Chen H.

Clin Drug Investig. 2013 Jan;33(1):1-9. doi: 10.1007/s40261-012-0010-8.

PMID:
23179471
10.
11.

Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.

Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.

Clin Ther. 2009 Feb;31(2):399-410. doi: 10.1016/j.clinthera.2009.02.002.

PMID:
19302912
12.
13.
14.
18.
19.

Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.

Galán-Herrera JF, Poo JL, Maya-Barrios JA, de Lago A, Oliva I, González-de la Parra M, Jiménez P, López-Bojórquez E, Burke-Fraga V, Namur S.

Clin Ther. 2008 Sep;30(9):1667-74. doi: 10.1016/j.clinthera.2008.09.011.

PMID:
18840372
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk